EZH2 and neoplasm: MELK promotes tumorigenesis and progression via activation of PI3K/Akt/mTOR signaling, stabilization of EZH2, histone methylation, and regulation of the tumor immune microenvironment (Xu et al., 2020; Li et al., 2019; Yu et al., 2024; Tang et al., 2024).